Rosuvastatin is Superior Compared to Simvastatin and Atorvastatin to Induce Endothelial Progenitor Cells MigrationCorrespondence Address :
Yudi Her Oktaviono,
Jl. Mayjend. Prof. Dr. Moestopo No.6-8, Surabaya, East Java, Indonesia.
Introduction: Statins have shown to improve Endothelial Progenitor Cells (EPCs) function, however no comparison has been done between various statins effectivity to induce EPCs migration.
Aim: This study compared simvastatin, atorvastatin and rosuvastatin treatment on impaired EPCs from Coronary Artery Disease (CAD) patients.
Materials and Methods: EPCs were isolated, cultivated and divided into untreated group (control), simvastatin (dose 0.1, 0.25, 0.5 mM), atorvastatin (0.1, 0.25, 0.5 mM), rosuvastatin (0.1, 0.25, 0.5 mM). EPCs migration was evaluated with boyden chamber assay. ANOVA, pearson correlation and linear regression test were done using SPSS 25.0.
Results: This research showed that simvastatin, atorvastatin, and rosuvastatin increased EPCs migration in dose dependent manner (p<0.05). Regression test showed that simvastatin treatment was responsible for 92.9% of EPCs migration, while atorvastatin was 75.5% and rosuvastatin was 65.6%. Rosuvastatin treatment dose 0.5 mM have the highest EPCs migration effect (195,750.00±5,809.48) compared to simvastatin (123,750.00±9,367.50, p=0.001) and atorvastatin (156,375.00±12,392.03, p=0.001) at the same dose.
Conclusion: Rosuvastatin treatment has higher EPCs migration effect compared to simvastatin and atorvastatin. This suggests that rosuvastatin might be preferable to improve EPCs migration in CAD patients.
Coronary artery disease, Impaired EPCs, Statins, Vascular regeneration
Yudi Her Oktaviono, Makhyan Jibril Al Farabi, Feranti Meuthia, Tyagita Verdena Rani Savitri, Djoko Soemantri. ROSUVASTATIN IS SUPERIOR COMPARED TO SIMVASTATIN AND ATORVASTATIN TO INDUCE ENDOTHELIAL PROGENITOR CELLS MIGRATION. Journal of Clinical and Diagnostic Research [serial online] 2019 May [cited: 2019 May 19 ]; 13:OC05-OC08. Available from
Date of Submission: Mar 11, 2019
Date of Peer Review: Mar 20, 2019
Date of Acceptance: Apr 01, 2019
Date of Publishing: May 01, 2019
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)